However, lower response rates to immune checkpoint blockades have been observed in acral melanoma and nail unit melanoma, which may be due to smaller numbers of tumor-infiltrating lymphocytes, lower PD-L1 expression, and a lower mutational burden in acral melanoma compared with other subtypes of melanoma [71]. This evidence concerns the gene CD274 and melanoma.